IMPETIS BIOSCIENCES

Impetis Biosciences, an IP focused drug discovery and licensing company, has developed therapeutic assets in the areas of auto-immune and inflammatory diseases and immuno-oncology... Impetis was founded in 2017 and is built around high value therapeutic candidates discovered by the highly talented and experienced scientific team at Advinus Therapeutics. Impetis was spun out as an independent Drug Discovery company focused on developing IP based on NCEs for critical therapy areas... Impetis has created a pipeline of candidate drugs for selected Therapeutic Areas based on critical targets and pathways that are implicated in the development of pathophysiology in these disease areas. We have selected candidates that show differentiated and superior efficacy, and are backed by solid pre-clinical proof-of-concept data in well-designed studies in relevant disease models and assays. Our nominated clinical candidates have been designed to have an optimal Target Product Profile and can be..

Also known as: Impetis, Impetis Biosciences Limited, Impetis Biosciences Ltd.